Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images

被引:4
作者
Han, Qiuyue [1 ,2 ]
Lu, Yiping [1 ]
Wang, Dongdong [1 ]
Li, Xuanxuan [1 ]
Ruan, Zhuoying [1 ]
Mei, Nan [1 ]
Ji, Xiong [3 ]
Geng, Daoying [1 ,4 ]
Yin, Bo [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Radiol, 12 Wulumuqi Rd Middle, Shanghai 200040, Peoples R China
[2] Shanghai Inst Med Imaging, Shanghai, Peoples R China
[3] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai, Peoples R China
[4] Ctr Shanghai Intelligent Imaging Crit Brain Dis En, Shanghai, Peoples R China
关键词
Glioblastoma; Magnetic resonance imaging; Radiomics; INTRATUMORAL HETEROGENEITY; HISTOGRAM ANALYSIS; ASTROCYTIC TUMORS; EDEMA; SURVIVAL; EXPRESSION; THERAPY; GLIOMAS; ATRX; ANGIOGENESIS;
D O I
10.1007/s00330-023-09924-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesGlioblastoma (GB) without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity is atypical and its characteristics are barely known. The aim of this study was to explore the differences in pathological and MRI-based intrinsic features (including morphologic and first-order features) between GBs with peritumoral FLAIR hyperintensity (PFH-bearing GBs) and GBs without peritumoral FLAIR hyperintensity (PFH-free GBs).MethodsIn total, 155 patients with pathologically diagnosed GBs were retrospectively collected, which included 110 PFH-bearing GBs and 45 PFH-free GBs. The pathological and imaging data were collected. The Visually AcceSAble Rembrandt Images (VASARI) features were carefully evaluated. The first-order radiomics features from the tumor region were extracted from FLAIR, apparent diffusion coefficient (ADC), and T1CE (T1-contrast enhanced) images. All parameters were compared between the two groups of GBs.ResultsThe pathological data showed more alpha thalassemia/mental retardation syndrome X-linked (ATRX)-loss in PFH-free GBs compared to PFH-bearing ones (p < 0.001). Based on VASARI evaluation, PFH-free GBs had larger intra-tumoral enhancing proportion and smaller necrotic proportion (both, p < 0.001), more common non-enhancing tumor (p < 0.001), mild/minimal enhancement (p = 0.003), expansive T1/FLAIR ratio (p < 0.001) and solid enhancement (p = 0.009), and less pial invasion (p = 0.010). Moreover, multiple ADC- and T1CE-based first-order radiomics features demonstrated differences, especially the lower intensity heterogeneity in PFH-free GBs (for all, adjusted p < 0.05).ConclusionsCompared to PFH-bearing GBs, PFH-free ones demonstrated less immature neovascularization and lower intra-tumoral heterogeneity, which would be helpful in clinical treatment stratification.
引用
收藏
页码:9139 / 9151
页数:13
相关论文
共 41 条
  • [1] Metabolic heterogeneity and adaptability in brain tumors
    Badr, Christian E.
    Silver, Daniel J.
    Siebzehnrubl, Florian A.
    Deleyrolle, Loic P.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (24) : 5101 - 5119
  • [2] Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
    Bellail, AC
    Hunter, SB
    Brat, DJ
    Tan, C
    Van Meir, EG
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (06) : 1046 - 1069
  • [3] Relationship between survival and edema in malignant gliomas: Role of vascular endothelial growth factor and neuronal pentraxin 2
    Carlson, Marc R. J.
    Pope, Whitney B.
    Horvath, Steve
    Braunstein, Jerome G.
    Nghiemphu, Phioanh
    Tso, Cho-Lea
    Mellinghoff, Ingo
    Lai, Albert
    Liau, Linda M.
    Mischel, Paul S.
    Dong, Jun
    Nelson, Stanley F.
    Cloughesy, Timothy F.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (09) : 2592 - 2598
  • [4] Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival
    Chaurasia, Ajay
    Park, Sung-Hye
    Seo, Jeong-Wook
    Park, Chul-Kee
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (08) : 1208 - 1214
  • [5] Chen Wen-Jie, 2015, Asian Pac J Cancer Prev, V16, P411
  • [6] Assessment of tumor heterogeneity: An emerging imaging tool for clinical practice?
    Davnall F.
    Yip C.S.P.
    Ljungqvist G.
    Selmi M.
    Ng F.
    Sanghera B.
    Ganeshan B.
    Miles K.A.
    Cook G.J.
    Goh V.
    [J]. Insights into Imaging, 2012, 3 (6) : 573 - 589
  • [7] Gliomas and the vascular fragility of the blood brain barrier
    Dubois, Luiz Gustavo
    Campanati, Loraine
    Righy, Cassia
    D'Andrea-Meira, Isabella
    de Sampaio e Spohr, Tania Cristina Leite
    Porto-Carreiro, Isabel
    Pereira, Claudia Maria
    Balca-Silva, Joana
    Kahn, Suzana Assad
    DosSantos, Marcos F.
    Rabello Oliveira, Marcela de Almeida
    Ximenes-da-Silva, Adriana
    Lopes, Maria Celeste
    Faveret, Eduardo
    Gasparetto, Emerson Leandro
    Moura-Neto, Vivaldo
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [8] Rous-Whipple Award Lecture - How tumors make bad blood vessels and stroma
    Dvorak, HF
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) : 1747 - 1757
  • [9] Hypoxia is important in the biology and aggression of human glial brain tumors
    Evans, SM
    Judy, KD
    Dunphy, I
    Jenkins, WT
    Hwang, WT
    Nelson, PT
    Lustig, RA
    Jenkins, K
    Magarelli, DP
    Hahn, SM
    Collins, RA
    Grady, MS
    Koch, CJ
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8177 - 8184
  • [10] VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
    Gerstner, Elizabeth R.
    Duda, Dan G.
    di Tomaso, Emmanuelle
    Ryg, Peter A.
    Loeffler, Jay S.
    Sorensen, A. Gregory
    Ivy, Percy
    Jain, Rakesh K.
    Batchelor, Tracy T.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (04) : 229 - 236